Page 1 | Search Results | Blood | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-4 of 4

Sort by

Sort Order Select

Journal Articles

New chronic lymphocytic leukaemia therapies: Does measurable residual disease testing accurately predict progression-free survival

Yun Wang, Chunhua Li, Robert Gale, Qi Liang, Neil Kay, Victoria Wang, Qianqian Huang, Yiling Song, Weida Wang, Yang Liang

Blood (2025) 146 (Supplement 1): 2132.

https://doi.org/10.1182/blood-2025-2132

Published: 2025

Journal Articles

Integrated machine learning-based prognostic models for patients with Myelodysplastic Syndromes/neoplasms (MDS)

Xin Wang, Qiujin Shen, Saibing Qi, Xiaowen Gong, Tiejun Qin, Zefeng Xu, Bing Li, Shiqiang Qu, Binhan Jiang, Yue Zhong, Lijuan Pan, Meng Jiao, Qingyan Gao, Robert Gale, Junren Chen, Zhijian Xiao

Blood (2025) 146 (Supplement 1): 7385.

https://doi.org/10.1182/blood-2025-7385

Published: 2025

Journal Articles

CD123-targeted radiotheranostics of Acute Myeloid Leukemia with 89Zr/177Lu-labeled pivekimab

Qichen Hu, Yijing Zhao, Siqi Zhang, Kun Wang, Xin Gao, Dengfu Wu, Jieting Shen, Qingshuang Lu, Xuekai Song, Quan Zuo, Robert Gale, Rui Wang, Xiaojun Huang, Kuan Hu

Blood (2025) 146 (Supplement 1): 5052.

https://doi.org/10.1182/blood-2025-5052

Published: 2025

Journal Articles

Phase-3 study of vamotinib (PF-114) versus high-dose imatinib

Anna Turkina, Olga Vinogradova, Nuriya Kalimulina, Tatyana Shelekhova, Igor Davydkin, Bulat Bakirov, Tatiana Pospelova, Elza Lomaia, Jitendra Pehalajani, Vishvdeep Khushoo, Shashikant Apte, Robert Gale, Ghermes Chilov

Blood (2025) 146 (Supplement 1): 7290.

https://doi.org/10.1182/blood-2025-7290

Published: 2025